5 Things Valeant's Management Said That You Probably Wish It Hadn't [The Motley Fool]
VALEANT PHARMACEUTICALS (VRX)
Last valeant pharmaceuticals earnings: 2/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.valeant.com
Company Research
Source: The Motley Fool
There was plenty of bad news from Valeant Pharmaceuticals executives in the Q4 earnings call. You only needed to look at Valeant Pharmaceuticals ' ( NYSE:VRX ) share price on Tuesday to know that things didn't go well when the company reported its fourth-quarter results. As bad as those results were, though, it was Valeant's outlook for 2017 that really caused the stock to plunge over 13%. Valeant executives did their best to point to the company's efforts to right the ship. And some of what they said was encouraging. However, most of it wasn't. Here are five things, in particular, that Valeant's management said that shareholders probably wish it hadn't. (Quotes from S&P Global Market Intelligence .) Image source: Getty Images. 1. We'll spend around $1.85 billion on interest in 2017. CFO Paul Herendeen noted that Valeant expects to spend roughly $1.85 billion this year on interest payments. Around $100 million of that amount will be amortization of deferred
Show less
Read more
Impact Snapshot
Event Time:
VRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRX alerts
High impacting VALEANT PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics